Clinical trials

  • LORLATINIB for Advanced ALK-positive non-small cell lung cancer
  • CAPECITABINE for Early-stage rectal cancer
  • Durvalumab for Extrahepatic cholangiocarcinoma
  • Carboplatin for Adult medulloblastoma | Medulloblastoma
  • METHYLPREDNISOLONE ACETATE; LIDOCAINE HYDROCHLORIDE for Arthritis of the temporomandibular joint
  • REMIBRUTINIB for Generalized myasthenia gravis|Myasthenia gravis
  • ELAFIBRANOR for Primary sclerosing cholangitis
  • APALUTAMIDE for Castration-resistant prostate cancer
  • EVORPACEPT for Advanced HER2-overexpressing gastric adenocarcinoma | Advanced HER2-overexpressing gastroesophageal junction adenocarcinoma
  • ARGIPRESSIN for Septic shock
  • EVOLOCUMAB for Acute myocardial infarction (NSTEMI and STEMI)|Dyslipidemia|Hypercholesterolemia
  • FLUOROURACIL for Resectable gastric adenocarcinoma | Gastroesophageal junction adenocarcinoma